Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × Classical hematology × Clear all

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT06802146 2025-03-27

Early Intervention in High Risk CCUS

Phase EARLY_PHASE1 Recruiting

Classical hematology

Cytopenia

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Phase EARLY_PHASE1 Completed

Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

Phase EARLY_PHASE1 Terminated

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Phase EARLY_PHASE1 Withdrawn

Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis